Page last updated: 2024-10-24

basement membrane organization

Definition

Target type: biologicalprocess

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the basement membrane. [GOC:mah]

Basement membrane organization is a complex and tightly regulated process that involves the coordinated assembly of specialized extracellular matrix (ECM) components. This intricate structure serves as a crucial interface between epithelial and mesenchymal cells, providing structural support, regulating cell behavior, and influencing tissue development and function.

The formation of the basement membrane begins with the deposition of a specialized type of collagen, type IV collagen, which forms a network-like scaffold. This network is further stabilized by the addition of other ECM proteins, including laminins, nidogens, and perlecan. Laminins are heterotrimeric proteins that bind to type IV collagen and other ECM components, contributing to the structural integrity and organization of the basement membrane. Nidogens act as bridging molecules, linking laminins to type IV collagen and perlecan, enhancing the stability of the network. Perlecan, a large heparan sulfate proteoglycan, provides binding sites for growth factors and other signaling molecules, playing a role in cell-matrix interactions and signaling pathways.

The assembly of the basement membrane is not a random process. It is precisely regulated by a complex interplay of cell-derived signals and ECM components. Cells secrete specific factors that influence the deposition and organization of the basement membrane, including growth factors, proteases, and enzymes. These factors can regulate the synthesis, assembly, and degradation of ECM proteins, ensuring the proper formation and maintenance of the basement membrane.

The organization of the basement membrane is highly dynamic and can be remodeled in response to changes in cellular needs and environmental cues. This remodeling process involves the degradation of existing ECM components and the deposition of new ones. Proteases, such as matrix metalloproteinases (MMPs), play a crucial role in the breakdown of the basement membrane. Their activity is tightly regulated to prevent excessive degradation and maintain tissue integrity.

The basement membrane plays a critical role in various biological processes, including tissue development, cell migration, and angiogenesis. It provides structural support for epithelial cells, maintains tissue integrity, and regulates cell behavior by presenting specific ligands that interact with cell surface receptors. The basement membrane also serves as a barrier, controlling the movement of molecules and cells between tissues.

In conclusion, basement membrane organization is a sophisticated process that involves the coordinated assembly of ECM components. This dynamic structure plays a crucial role in tissue development, cell behavior, and overall tissue function. The precise regulation of its formation, maintenance, and remodeling is essential for maintaining tissue homeostasis and ensuring proper organ function.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Stromelysin-3A stromelysin-3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P24347]Homo sapiens (human)
Integrin beta-1An integrin beta-1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P05556]Homo sapiens (human)

Compounds (18)

CompoundDefinitionClassesRoles
haloperidolhaloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol
antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
1,3-ditolylguanidine1,3-ditolylguanidine: structure given in first source; a selective ligand for the sigma binding sites in the braintoluenes
tirofibantirofiban : A member of the class of piperidines that is L-tyrosine in which a hydrogen attached to the amino group is replaced by a butylsulfonyl group and in which the hydrogen attached to the phenolic hydroxy group is replaced by a 4-(piperidin-4-yl)butyl group.

Tirofiban: Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in the treatment of ACUTE CORONARY SYNDROME.
L-tyrosine derivative;
piperidines;
sulfonamide
anticoagulant;
fibrin modulating drug;
platelet glycoprotein-IIb/IIIa receptor antagonist
arginyl-glycyl-aspartic acidarginyl-glycyl-aspartic acid: amino acid sequence of basic unit of widespread cellular recognition systemoligopeptide
arginyl-glycyl-aspartyl-serinearginyl-glycyl-aspartyl-serine: corresponds to cell attachment site of fibronectin; located near carboxyl-terminal region of alpha-chain of fibrinogen; inhibits platelet aggregation & fibrinogen binding to activated platelets
glycyl-arginyl-glycyl-aspartyl-serineglycyl-arginyl-glycyl-aspartyl-serine: synthetic peptide from fibronectins; inhibits experimental metastasis of murine melanoma cells
d-arg-gly-asp-trparginyl-glycyl-aspartyl-tryptophan: a synthetic RGD-containing peptide
l 738167L 738167: structure in first source
cilengitideCilengitide: an alphaVbeta3 integrin antagonist that paralyzes cancer cellsoligopeptide
l 734217L 734217: fibrinogen receptor antagonist; structure given in first source
cyclopaminepiperidinesglioma-associated oncogene inhibitor
arginyl-glycyl-aspartyl-phenylalanine
cyclic(arg-gly-asp-d-phe-val)
mk-0429
mocetinostatmocetinostat : A benzamide obtained by formal condensation of the carboxy group of 4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzoic acid with one of the amino groups of benzene-1,2-diamine. It is an orally active and isotype-selective HDAC inhibitor which exhibits antitumour activity (IC50 = 0.15, 0.29, 1.66 and 0.59 muM for HDAC1, HDAC2, HDAC3 and HDAC11).

mocetinostat: undergoing phase II clinical trials for treatment of cancer
aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
tr 14035N-(2,6-dichlorobenzoyl)-4-(2',6'-bismethoxyphenyl)phenylalanine: TR-14035 is the (L)-isomer; an antagonist of both alpha4beta1 and beta7 integrins; structure in first source
bio 1211BIO 1211: integrin alpha4beta1 inhibitor; structure in first source
grassystatin agrassystatin A: isolated from a cyanobacterium, identified as Lyngbya cf.; structure in first source